RELEASE
Gov. Rick Snyder Appoints Blue Cross' Laurie Wesolowicz to Michigan's Prescription Drug and Opioid Abuse Commission
Brianna Neace
| 2 min read
On Monday, September 12, Gov. Rick Snyder announced the initial appointments to the Michigan Prescription Drug and Opioid Abuse Commission, created by the Executive Order he signed in June. The 21-member Commission, housed within the Department of Licensing and Regulatory Affairs, will review the Report of Findings and Recommendations for Action from the Michigan Prescription Drug and Opioid Abuse Task Force and develop and propose policies and an action plan to implement the recommendation from the report. “Prescription drug and opioid abuse is a very serious issue impacting people in communities all across our state,” Snyder said. “Members of this commission will work on the necessary steps to help prevent drug-related deaths in Michigan.” The creation of the commission was a recommendation of the Prescription Drug and Opioid Abuse Task Force the Governor created last year that was chaired by Lt. Gov. Brian Calley. Other recommendations can be found in the statewide action plan. Among Gov. Snyder's 21 total appointments is Dr. Laurie Wesolowicz of Northville. She serves as Director II of Pharmacy Services Clinical for Blue Cross Blue Shield of Michigan, co-chair of the BCBSM Controlled Substance Workgroup and the BCBSM Pharmacy and Therapeutics Committee, as well as director of the PGY-1 Managed Care Residency Program. She holds a doctorate degree of pharmacy from the University of Michigan and will represent pharmacists on the commission. Members will serve two-year terms expiring on Sept. 1, 2018, and their appointments are subject to the advice and consent of the Senate. Photo Credit: Detroit Regional Chamber
